Bilastic-AM Tablet

Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg Tablets — Triple Anti-Allergy / Anti-Asthma Therapy

Bilastic-AM Tablet — Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg
Dosage Form Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 2750
Therapy Dermatology + Anti-Allergy + Respiratory — Antihistamine + Leukotriene Antagonist + Mucolytic-Bronchodilator
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Bilastic-AM Tablet

Bilastic-AM Tablet combines three complementary anti-allergy / anti-asthma molecules: Bilastine 20 mg (H1 antihistamine), Montelukast 10 mg (cysteinyl leukotriene receptor antagonist) and Acebrophylline 200 mg (mucolytic + mild bronchodilator). The triple combination is used for patients with concurrent allergic rhinitis and bronchial asthma — the so-called ‘united airway’ phenotype that drives most chronic respiratory allergy in Indian practice.

Bilastine blocks histamine-mediated rhinitis symptoms; Montelukast blocks leukotriene-mediated bronchoconstriction and mucosal swelling; Acebrophylline reduces mucus viscosity, stimulates surfactant production and provides mild bronchodilation. Together they address the inflammatory, bronchospastic and mucus-clearance components of allergic airway disease in a single daily tablet.

Bilastic-AM is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a high-margin respiratory/allergy SKU.

Indications

  • Allergic rhinitis with concurrent mild-to-moderate asthma
  • Persistent allergic asthma with rhinitis (united airway disease)
  • Cough-variant asthma with allergic component
  • Post-viral airway hyperreactivity with allergic background

Mechanism of Action

Bilastine selectively blocks H1 receptors, suppressing histamine-driven rhinitis and itch. Montelukast antagonises CysLT1 leukotriene receptors on airway smooth muscle and inflammatory cells, reducing bronchoconstriction and eosinophilic inflammation. Acebrophylline is a xanthine derivative + ambroxol salt — providing mucolytic, surfactant-stimulating and mild PDE-inhibitor bronchodilator action.

Dosage & Administration

Adults: 1 tablet once daily in the evening, swallowed whole. Re-evaluate response after 4 weeks. Step down to monotherapy when symptoms stabilise.

Side Effects

Headache, mild GI upset, somnolence (low), behavioural changes (Montelukast — black-box warning for neuropsychiatric effects; counsel patient and monitor). Acebrophylline class: occasional GI upset, palpitations, tremor.

Contraindications & Precautions

Hypersensitivity to any component. Severe hepatic impairment. Concomitant fruit juices (reduce Bilastine absorption). History of suicidal ideation (Montelukast caution). Acute severe asthma exacerbation — not for rescue therapy.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Bilastic-AM Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Bilastic-AM Tablet used for?

Bilastic-AM combines Bilastine + Montelukast + Acebrophylline and is used for patients with concurrent allergic rhinitis and asthma — addressing rhinitis, bronchoconstriction and mucus clearance in a single daily tablet.

What is the Montelukast neuropsychiatric warning?

Montelukast has a US-FDA black-box warning for neuropsychiatric effects (mood changes, suicidal ideation). Patients and caregivers should be counselled to report any unusual mood or behavioural changes immediately.

Is Bilastic-AM available for PCD pharma franchise?

Yes, Trumac Healthcare offers Bilastic-AM Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Bilastic-AM Tablet be stored?

Store below 30 °C in a dry place, away from direct sunlight and moisture.

Is Bilastic-AM WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.